Target intelligence / Profile preview

Mortality factor 4 like 1 pseudogene 1 (MORF4L1P1)

Target
MORF4L1P1
Molecular classification
Other (Pseudogene; non-coding RNA)
01

Overview

Mortality factor 4 like 1 pseudogene 1 (MORF4L1P1), also abbreviated as MRG1, is classified as a pseudogene, meaning it is a genomic DNA sequence similar to the functional Mortality factor 4 like 1 gene (MORF4L1) but incapable of encoding a functional protein due to mutations, insertions, or deletions that disrupt translation[5]. Whereas the parental gene MORF4L1 encodes a protein involved in chromatin modification, DNA repair, and transcriptional regulation, MORF4L1P1 retains sequence similarity but does not produce a functional protein[5][1]. There is no evidence that MORF4L1P1 functions as an enzyme, receptor, transporter, or other therapeutic target class. Pseudogenes such as MORF4L1P1 can sometimes regulate their parental genes or related pathways through RNA-mediated mechanisms, such as acting as microRNA (miRNA) decoys ("competing endogenous RNAs"), therefore potentially influencing the expression of related protein-coding genes[2][3][4][6]. However, there is no specific, experimentally validated evidence for such a role for MORF4L1P1 in regulation or disease. Its biological relevance is therefore largely theoretical and derived from the broader study of pseudogenes. Key Technical Notes: - The target is not a canonical therapeutic target (e.g., receptor, enzyme, transporter), does not fit into those classifications, and should not be considered druggable[5]. - The name "MRG1" in reference to "Mortality factor 4 like 1 pseudogene 1" is not standard; "MRG1" is more often used for other contexts, if at all. The main accepted gene name is "MORF4L1P1". - No drugs, biomarkers, or clinical indications are described for this pseudogene. - Its "incorrect" flag is set to true because as a pseudogene, it is not an actionable target or receptor in the therapeutic sense, and searching for it as such may reflect a misinterpretation of its biological role[5]. Summary: MORF4L1P1 is a human pseudogene with no protein product or established therapeutic relevance. Its function, if any, would likely involve RNA-level regulation of its parental gene, not direct biological activity or classic druggability.

Other names
MRG1Mortality factor 4 like 1 pseudogene 1
02

Biological functions

Other (Potential competing endogenous RNA/miRNA decoy based on pseudogene biology; not protein-coding)
03

Disease associations

Other (Limited evidence; general pseudogene regulatory roles in cancer and other diseases via parental gene regulation[2][3][4][6])

Beyond the preview

Go deeper on Mortality factor 4 like 1 pseudogene 1 (MORF4L1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mortality factor 4 like 1 pseudogene 1 (MORF4L1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call